Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Acne keloidalis nuchae is a tough-to-treat condition that greatly affects quality of life, especially in men of African descent.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Different races and genders have unique skin and hair issues, requiring specialized care and more research for effective treatment.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

Robotic hair transplants are easier and quicker to learn than traditional methods.

Adult women with acne in Iraq often have more severe symptoms and hormone-related issues than younger girls with acne.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.